General Biologicals

General Biologicals EPS

The Earnings per Share (EPS) of General Biologicals (4117.TWO) as of Nov 4, 2026 is 7.79 TWD. In the previous year, Earnings per Share (EPS) was -3.69 TWD — a change of -310.96% (higher).

EPS

7.79TWD

YoY

-310.96%

Last updated:

Earnings per Share (EPS) of General Biologicals is 2025 7.79 TWD. Earnings per Share (EPS) of General Biologicals was 2024 -3.69 TWD. It decreases by -310.96% higher compared to the previous year.

The General Biologicals EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-1.56 TWD
Jan 1, 2019
-0.65 TWD
Jan 1, 2020
1.04 TWD
Jan 1, 2021
0.74 TWD
Jan 1, 2022
-0.89 TWD
Jan 1, 2023
-3.32 TWD
Jan 1, 2024
-3.69 TWD
Jan 1, 2025
7.79 TWD
The General Biologicals EPS history
YEAREPSYoY
7.79TWD-310.96%
-3.69TWD+11.06%
-3.32TWD+273.80%
-0.89TWD-220.50%
0.74TWD-28.98%
1.04TWD-259.17%
-0.65TWD-58.13%
-1.56TWD-17.22%
-1.88TWD-10.85%
-2.11TWD+4.19%
-2.03TWD+162.96%
-0.77TWD-496.04%
0.19TWD-59.98%
0.49TWD+115.78%
0.23TWD+7.84%
0.21TWD-202.54%
-0.20TWD+12.71%
-0.18TWD-40.23%
-0.30TWD-81.75%
-1.66TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

Earnings per Share (EPS) of General Biologicals is 7.79 TWD in 2025.

Earnings per Share (EPS) of General Biologicals changed from -3.69 TWD to 7.79 TWD, representing a -310.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) General Biologicals since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — General Biologicals

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — General Biologicals